Skip to content

Open Trial of Behavioral Activation and Social Engagement (BASE) for Posttraumatic Stress Disorder (PTSD)

Open Trial of Behavioral Activation and Social Engagement (BASE) for Posttraumatic Stress Disorder (PTSD)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03191760
Acronym
PTSD
Enrollment
27
Registered
2017-06-19
Start date
2017-06-08
Completion date
2020-02-18
Last updated
2023-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-Traumatic Stress Disorder

Keywords

Posttraumatic Stress Disorder, Social Support, Primary Care

Brief summary

The purpose of the study is to see if Behavioral Activation and Social Engagement for PTSD (BASE for PTSD), an individual therapy for PTSD, will help Veterans with PTSD 1) through improved understanding of how PTSD affects them, 2) by reducing ways in which they avoid meaningful activity due to PTSD, 3) by enabling them to do more of the things they really care about, and 4) by improving, strengthening, and building up their social supports.

Detailed description

Posttraumatic stress disorder (PTSD) is a mental health condition that some people develop following exposure to a traumatic event. PTSD often results in a reduction in feelings of connection to other people and changes in views about others, as well as reduced participation in valued activities. Many veterans with PTSD do not seek treatment offered in specialty mental health settings and may forgo treatment of any kind. This study is an open-trial format (no comparison condition) of U.S. military veterans who will participate in a brief psychotherapy treatment for PTSD offered in a Primary Care setting. This is a pilot trial to see if the treatment is effective at reducing symptoms of PTSD and increasing feelings of social support, and an exploratory aim is to see if veterans engage in additional treatment after completing this treatment.

Interventions

BEHAVIORALBehavioral Activation

Participants will be asked to attend 6 in-person or phone-mediated therapy sessions lasting approximately 45 minutes per session, to be held in Primary Care settings. Content of therapy sessions includes education about PTSD symptoms, discussion of the role of avoidance in maintaining PTSD symptoms, self-monitoring homework to identify links between activity level and emotions, and homework designed to increase engagement in valued activities, with a focus on increasing social contact and support. If relevant, participants will be instructed in basic communication skills, social skills, and relaxation skills.

Sponsors

VA Puget Sound Health Care System
Lead SponsorFED

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Veterans who: 1. are currently enrolled in either of the Primary Care Clinics (including Women's Clinic) or Primary Care Mental Health Integration clinic at VA Puget Sound Health Care System - Seattle Division 2. meet criteria for clinical or subclinical PTSD 3. are willing to have therapy sessions audiotaped for the purposes of supervision 4. plan to live in the Seattle area for 6 months following entry into the study

Exclusion criteria

* Veterans who: 1. exhibit the presence of severe mental illness diagnosis (e.g., active psychosis and/or uncontrolled bipolar disorder) 2. have been a psychiatric in-patient admission in the past 30 days 3. have had a suicide attempt in the last 60 days 4. have had a plan or intent to harm self or others in the last 30 days 5. have a behavioral flag in their medical record 6. have had a psychiatric medication dosing or receipt that has changed in the last 30 days 7. are unwilling to provide at least 1 collateral contact 8. have impaired decision making capacity (as measured by evidence in the Computerized Patient Record System record of moderate-severe Traumatic Brain Injury, uncontrolled psychosis, dementia, communication flag, or by clinical judgment in speaking with the participant 9. are prisoners 10. are illiterate or have limited or no English proficiency 11. are terminally ill 12. are currently participating in Cognitive Processing Therapy (CPT) or Prolonged Exposure Therapy (PE)

Design outcomes

Primary

MeasureTime frameDescription
Behavioral Activation for Depression Scalebaseline to 4 weeks, 4 weeks to 8 weeks, 8 weeks to 12 weeksChange in activity level
PTSD Checklist-Military Versionbaseline to 4 weeks, 4 weeks to 8 weeks, 8 weeks to 12 weeksChange in PTSD symptoms
Medical Outcomes Study Social Support Survey Form and Social Connectedness Scale - Revisedbaseline to 4 weeks, 4 weeks to 8 weeks, 8 weeks to 12 weeksChange in social support
Patient Health Questionnaire-9baseline to 4 weeks, 4 weeks to 8 weeks, 8 weeks to 12 weeksChange in Depression symptoms
Network Orientation Scalebaseline to 4 weeks, 4 weeks to 8 weeks, 8 weeks to 12 weeksChange in social network orientation

Secondary

MeasureTime frameDescription
Additional treatment engagement16 weeksmeasured via medical record review
Brief COPEbaseline to 4 weeks, 4 weeks to 8 weeks, 8 weeks to 12 weeksChange in coping strategies
Social Connectedness Scale - Revised (SCS-R)baseline to 4 weeks, 4 weeks to 8 weeks, 8 weeks to 12 weeksChange in the level of interpersonal closeness related to participants' social environment and the degree of difficulty experienced by participants in sustaining the sense of closeness
Qualitative assessment12 weeksParticipants' reactions to the treatment will be gathered in qualitative interviews assessing treatment experience, perceptions of treatment focus, engagement with valued activities, social support, therapeutic relationship

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026